These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12450235)

  • 1. Glicoprotein (GP) IIb/IIIa inhibitors for acute stroke treatment.
    Bogousslavsky J; Paciaroni M; Gallai V
    Clin Exp Hypertens; 2002; 24(7-8):603-10. PubMed ID: 12450235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in the management of ischemic stroke.
    Lapchak PA; Araujo DM
    Am J Cardiovasc Drugs; 2003; 3(2):87-94. PubMed ID: 14727935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.
    Ciccone A; Abraha I; Santilli I
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005208. PubMed ID: 17054247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activation as a potential mechanism of GP IIb/IIIa inhibitor-induced thrombocytopenia.
    Peter K; Straub A; Kohler B; Volkmann M; Schwarz M; Kübler W; Bode C
    Am J Cardiol; 1999 Sep; 84(5):519-24. PubMed ID: 10482148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.
    Dyke CM
    Am Heart J; 1999 Oct; 138(4 Pt 2):307-16. PubMed ID: 10502236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet glycoprotein IIb/IIIa antagonists for acute ischemic stroke.
    Bogousslavsky J; Leclerc JR
    Neurology; 2001; 57(5 Suppl 2):S53-7. PubMed ID: 11552056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.
    Campbell KR; Ohman EM; Cantor W; Lincoff AM
    Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet glycoprotein IIb/IIIa blockade in acute ischemic stroke.
    Bogousslavsky J; Leclerc JR
    Cerebrovasc Dis; 2001; 11(4):287-93. PubMed ID: 11385206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence.
    Pancioli AM; Brott TG
    CNS Drugs; 2004; 18(14):981-8. PubMed ID: 15584768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy for early reperfusion after stroke.
    Juttler E; Kohrmann M; Schellinger PD
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):656-63. PubMed ID: 17122798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study].
    Franzosi MG
    Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination therapy for acute myocardial infarction: fibrinolytic therapy and glycoprotein IIb/IIIa inhibition.
    Califf RM
    Am Heart J; 2000 Feb; 139(2 Pt 2):S33-7. PubMed ID: 10650314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic inhibitors of platelet glycoprotein IIb/IIIa in clinical development.
    Verstraete M
    Circulation; 2000 Feb; 101(6):E76-80. PubMed ID: 10673265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA
    Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlopidine.
    Peter K; Kohler B; Straub A; Ruef J; Moser M; Nordt T; Olschewski M; Ohman ME; Kübler W; Bode C
    Circulation; 2000 Sep; 102(13):1490-6. PubMed ID: 11004138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial.
    Lincoff AM; Bittl JA; Harrington RA; Feit F; Kleiman NS; Jackman JD; Sarembock IJ; Cohen DJ; Spriggs D; Ebrahimi R; Keren G; Carr J; Cohen EA; Betriu A; Desmet W; Kereiakes DJ; Rutsch W; Wilcox RG; de Feyter PJ; Vahanian A; Topol EJ;
    JAMA; 2003 Feb; 289(7):853-63. PubMed ID: 12588269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic treatment for acute ischaemic stroke.
    Mazumdar A; Derdeyn CP
    Expert Opin Pharmacother; 2006 Feb; 7(3):287-96. PubMed ID: 16448323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation.
    Nannizzi-Alaimo L; Alves VL; Phillips DR
    Circulation; 2003 Mar; 107(8):1123-8. PubMed ID: 12615789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy of intravenous glycoprotein IIB/IIIA inhibitors and tissue plasminogen activator for acute ischemic stroke.
    Dubey D; Banerjee C; Sawhney A; Sharma A; Alberts MJ
    Neurol India; 2014; 62(6):631-4. PubMed ID: 25591675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of platelets glycoprotein IIb/IIIa (GP IIb/IIIa) receptor: rationale for their use in clinical cardiology.
    Rossi ML; Zavalloni D
    Mini Rev Med Chem; 2004 Sep; 4(7):703-9. PubMed ID: 15379638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.